ID    AVR/I/SSAP53
ET    Clinical
PN    Magainin-2
PL    23 [Note: any special compound, if present in sequence, is not considered in length]
SR    Not available
SO    Xenopus laevis
TX    Animalia (Frog)
VL    Experimentally validated
XX
TO    VISA (the VISA strain was isolated from a clinical specimen submitted for routine bacteriological investigation to the Institute of Infectious Diseases and Public Health, Polytechnic University of Marche, Ancona, Italy)
IC    FIC = 0.458
TH    Magainin II exhibits low cytotoxicity towards mammalian cells, is non-hemolytic, and selectively disrupts bacterial membranes, demonstrating a favorable safety profile and broad antimicrobial activity.
XR    PubMed: 16797106
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: 2LSA_A
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: 2MAG_A
XR    UniProt: C0HKN6
XR    UniProt: P11006
XR    DrugBank: Not available
XX
SQ    SEQUENCE  
      GIGKFLHSAK KFGKAFVGEI MNS 
//

